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Medicinal plants, since times immemorial, 
have been used in virtually all cultures as a 
source of medicine.  The widespread use of 
herbal remedies and healthcare preparations, 
as those described in ancient texts such as 
the Vedas and the bible, and obtained form 
commonly used traditional herbs and 
medicinal plants, has been traced to the 
occurance of natural products with 
medicinal properties  
 
The use of traditional medicine and 
medicinal plants in most developing 
countries, as a normative basis for the 
maintenance of good health, has been 
widely observed (UNESCO, 1996).   
Furthermore, an increasing reliance on the 
use of medicinal plants in the industrialized 
societies has been traced to the extraction 
and development of several drugs and 
chemotherapeutics form these plants as well 
as form traditionally used rural herbal 
remedies (UNESCO, 1998) Moreover, in 
these societies, herbal remedies have 
become more popular in the treatment of 
minor ailments, and also on account of the 
increasing costs of personal health 
maintenance, indeed the market and public 
demand has been so great that there is a 
great risk that many medicinal plants, today, 
face either extinction or loss of genetic 
diversity. 
 
Background 
 
Medicine, in several developing countries, 
using local traditions and beliefs, is still the 
mainstay of health care.  As defined by 
WHO , health is a state of complete 
physical, mental, and social well being and 
not merely the absence of disease or 
infirmity. 
 
The practice of traditional medicine is 
widespread is china, India, Japan, Pakistan, 
Sri Lanka and Thailand. 
 
In china about 40% of the total medicinal 
consumption is attributed to traditional tribal 
medicines.  In Thailand, herbal medicines 
make use of legumes encountered in the 
caesalpiniaceae, the fabaceae, and the 
Mimosaceae.  In the mid-90s, it is estimated 
that receipts of more than US$2.5 billion 
have resulted form the sales of herbal 
medicines.  And, in Japan, Herbal medicinal 
preparation are more in demand than 
mainstream pharmaceutical products. 
 
Africa is a rich source of medicinal plants 
perhaps, the best known species is 
phytolacca dodecandra.  
 
Extracts of the plant, commonly known as 
endod, are used as an effective mollucicide 
to control schistosomiasis (Lemma, 1991).   
Other notable examples are catharanthus 
roseus, which yields anti-tumour agents such 
as vinblastine and vincristine; and Ricinus 
communis, which yields the laxative- castor 
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oil.  In Botswana, Lesotho, Namibia and 
south Africa, Harpagophytum procumbens 
is produced as a crude drug for export. 
Similarly, Hibiscus sabdariffa is exported 
from Sudan and Egypt.  Other exports are 
Pausinystalia yohimbe from Cameroon, 
Nigeria and Rwanda, which yields 
yohimbine; and Rauwolfia vomitotria, from 
Madagascar, Mozambique and Zaire, which 
is exploited to yield reserpine and ajmaline. 
 
The use of medicinal plants like Eupatorium 
perfoliatum (bonest), Podophyllum peltatus 
(mayapple), and Panax quinquefolium 
(ginseng) in the USA has long been 
associated with the American Indians.   
These plants have also been appreciated and 
recognized for their aesthetic and 
ornamental value.  In central America 
medicinal plants have been widely used – by 
the Maya Indians in Mexico, the Miskitos 
and surmus in Honduras and Nicaragua, the 
Pech, Lencas, and Xicaques in Honduras, 
the Pipiles in EI Salvador, the Talamancas in 
Costa Rica, and the Guaymis and Kunas in 
Panama. 
 
In Europe, some 1500 species of medicinal 
and aromatic plants are widely used in 
Albania, Bulgaria, Croatia, France, 
Germany, Hungary, Poland, Spian, Turkey, 
and the United Kingdom.  The Maltese 
islands constitute and apt example where 
medicinal plants are widely used in every 
day life as part of folk medicinal remedies 
(Lanfrance, 1992). 
 
ISSUES: 
 
Traditional and folklore medicine 
bequeathed from generation to generation is 
rich in domestic recipes and communal 
practice.  Encompassing concepts and 
methods for the protection and restoration of 
health, traditional medicine has served as a 
fount of alternative medicine, new 
pharmaceuticals, and healthcare products.   
The best known examples of traditional 
medicine, differing in concept and protocol, 
are well developed systems such as 
acupuncture and ayurvedic medicine that 
have been widely used to conserve human 
health in China and India.  
 
Developed systems such as acupuncture and 
ayruvedic medicine that have been widely 
used to conserve human health in China and 
India. 
 
Developed countries, in recent times, are 
turning to the use of traditional medicinal 
systems that involve the use of herbal drugs 
and remedies.  About 1400 herbal 
preparations are used widely, according to a 
recent survey in Member states of European 
Union.  Herbal preparations are popular and 
are on significance in primary healthcare in 
Belgium, France, Germany and Netherlands, 
Such popularity of healthcare plant-derived 
products has been traced to their increasing 
acceptance and use in the consmetic indurey 
as well as to increasing public costs in the 
daily maintenance of personal health and 
well being.  Examples of such beauty-
oriented therapeuticals are skin tissue 
regenerators, anti-wrinkling agents and anit-
age creams. 
 
Most dernmaceuticals are derved from algal 
extracts that are rich in minerals and the 
vitamin B group. 
 
Skincare products such as skin creams, skin 
tonics, etc.  derived from medicinal plants 
are grouped together as dernaceuticals.  Also 
amongst the poor, cures and drugs, derived 
from plants, constitute the main source of 
healthcare products. 
 
Gorman (1992) drew attention to the power 
of Chinese folk medicnal potions in treating 
maladies from eczema and malaria to 
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respiratory disorders.  In the quest for new 
medicines to treat old and emergent diseases 
such as malaria and AIDS, attention is now 
being given to discovering the active 
ingredients encountered in the treasury of 
over 5,000 Chinese herbs, plants and roots 
that have been used routinely and 
traditionally.  Quinghaosu and Chaihu are 
two such examples.  Whereas the former, 
called artemisinin and obtained from 
Artemisia annua is expected to yield, in the 
coming millennium, a potent new class of 
antimalarials, the latter, obtained from 
Bupleurum Chinese and used as a popular 
remedy for hepatitis is the focus of intense 
research by the Japanese pharmaceutical 
industry. More recently, the biochemistry of 
tianhuafen or cucumber is being studied in 
the USA to decipher the identity of 
compound Q, an extract used in China and 
credited with remedial and relief properties 
in AIDS sufferers. 
 
Medicinal plants are an integral component 
of ethnoverterinary medicine.  Farmers and 
pastoralists in several countries use 
medicinal plants in the maintenance and 
concervation of the healthcare of livestock.  
Intestinal disorders in cous, in Mexico, are 
treated with herbal extracts of Polakowshkia 
tacacco.  Dietary supplements such as 
vitamin A in poultry feeds in Uganda are 
supplied through enrichments of amaranth 
(Amaranthus sp.) It is estimated that 
medicinal plants, for several centuries, have 
been widely used as a primary source 
prevention and control of livestock diseases.  
In fact, interest of such use in the veterinary 
sector has resulted primarily from the 
increasing cost of livestock maintenance and 
the introduction of new technology in the 
production of veterinary medicines and 
vaccines. 
 
McGee (1998), Surveying the use of spice 
and their medicinal properties around the 
world, concluded that spices serve the 
adaptive pupose of reducing food-borne 
disease.  In reviewing relevant texts ranging 
from the preservative properties of spices 
against food spoilage to the present of 
antimicrobial substances that lay claim to 
the elimination of pathogenic organisms in 
food preparations, the case is made for a 
more objective analysis        and study of the 
medicinal properties of spices in victo rather 
than in victo.  A whole range of plant-
derived dietary supplement s, 
phytochemicals and pro-vitamins that assist 
in maintaining good health and combating 
disease are now being described as 
functional foods, nutriceuticals and 
nutraceuticals.  Table 1 provides some 
examples of national activities concerning 
medicinal plants in several developed and 
developing countries. 
 
Despite the increasing use of medicinal 
plants, their future, seemingly, is being 
threatened by complacency concerning their 
conservation.  Reserves of herbs and stocks 
of medicinal plants in developing countries 
are diminishing and in danger of extinction 
as a result of growing trade demands for 
cheaper healthcare products and new plant-
based therapeutic markets in preference to 
more expensive target-specific drugs and 
biopharmaceuticals.  Such concerns have 
stimulated positive legal and economic 
interest. 
 
Issues concerning intellectual property 
rights, compensation for loss of finance-rich 
biodiversity resources, and the acquisition 
and safeguarding of traditional healthcare 
knowledge are no longer neglected. 
 
Bioprospecting of new drugs from medicinal 
plants and the exploitation of unprotected 
traditional knowledge in starting up 
potentially new bioindustries are the focus 
of new monitoring measures.  Such concerns 
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that call for adherence to and observation of 
cultural and intellectual property rights have 
been addressed and enshrined in the chiang-
Mai and Kari – Oca declarations (Table 2).  
The first countries to seriously tackle these 
issues are china and India.  Indeed, 
programmes dealing with medicinal plant 
conservation, cultivation, community 
involvement and sustainable development 
being initiated elsewhere, could benefit 
immensely form the Chinese and Indian 
experiences (World Bank, 1997). 
 
Genetic biodiversity of traditional medicinal 
herbs and plants is continuously under the 
threat of extinction as a result of growth 
exploitation, environment-unfriendly 
harvesting techniques, loss of growth 
habitats and unmonitored trade of medicinal 
plants. 
 
Medicinal herbs, possessing penile potency 
properties and anti-cancer principles are the 
focus of smuggling to import markets in 
Germany, France, Switzerland, Japan, the 
U.K. and the U.S.A.  The best known 
example, in recent times, is that of tetu lakda 
(Nothadoytes foetida).  Commonly 
encountered in southern India and Sri lanka, 
the herb is exploited as a source of anti-
cancer drugs. 
 
On the other hand, Adonis vernalis, extinct 
in Italy and the Netherlands, is an 
endangered species in Germany, Slovakia, 
Sweden and Switzerland, Fortunately, to 
safeguard against such practices and losses, 
guidelines and licensing concerning the use 
of such plants are provided for in the 
convention on international Trade 
Endangered species of Wild Flora and Fauna 
(CITES). 
 
The industrial uses of medicinal plants are 
many.  These range from traditional 
medicines, herbal teas, and health foods 
such as nutircuticals to galenicals, 
phytopharmaceuticals and industrially 
produced pharmaceuticals,  Furthermore, 
medicinal plants constitute a source of 
valuable foreign exchange for most 
developing countries, as they are a ready 
source of drugs such as quinine and 
reserpine; galenicals like tinctures and of 
intermediates (e.g. diosgenin from Discorea 
Sp.) in the production of semi-synthetic 
drugs. 
 
The world market for plant derived 
chemicals pharamaceuticals, fragrances, 
flavours, and colour ingredients, alone 
excess several billion dollars per year.   
Classic examples of phytochemicals in 
biology and medicine include taxol, 
vincristine, vinblastine, colchicines as well 
as the Chinese antimalarial-artemisinin, and 
the Indian ayurvedic drug-forkolin.  Trade in 
medicinal plants is growing in volume and 
in exports.  It is estimated that the global 
trade in medicinal plants is US $ 800 million 
per year. 
The botanical market, inclusive of herbs and 
medicinal plants, in the U.S.A. is estimated, 
at retail, at approximately US$ 1.6 billion 
p.a China with exports of over 120,000 
tonnes p.a., and India with some 32,000 
tonnes p.a dominate the international 
markets.  It is estimated that Europe, 
annually imports about 400,00 t of 
medicinal plants with an average market 
value of US$ 1 billion form Africa and Asia.  
A growing awareness of this new 
contributor to the foreign-exchange reserves 
of several national treasuries is beginning to 
emerge.  To satisfy growing market 
demands, surveys are being conducted to 
unearth new plant sources of herbal 
remedies and medicines. 
 
In several industrialized societies, plant-
derived prescription drugs constitute and 
element in the maintenance of health.   
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Medicinal plants are an integral component 
of research developments in the 
pharmaceutical industry.  Such research 
focuses on the isolation and direct use of 
active medicinal constitutents, or on the 
development of semi-synthetic drugs, or still 
again on the active screening of natural 
products to yield synthetic 
pharmacologically-active compounds.  In 
Germany, for example, over 1500 plant 
species encountered in some 200 familes 
and 800 genera have been processed into 
medicnal products.  In South Africa, 
likewise, some 500 species are 
commercialized trade products.  Today, 
Bulgaria, Germany and Poland are 
recognized as major exporters of plant-based 
medicinal products. 
 
The development and commercialization of 
medicinal plant-based bioindustries in the 
developing countries is dependent upon the 
availability of facilities and information 
concerning upstream and downstream 
bioprocessing, extraction, purification and 
marketing of the inductrial potential of 
medicinal plants.  Absence of such 
infrastructure compounded by lack of 
governmental interest and financial support 
restricts the evolution of traditional herbal 
extracts into authenticated market products.  
Furthermore the absencse of modernized 
socio-economic and public healthcare 
systems reinforce reliance of rural and 
lower-income urban populations on the use 
of traditional medicinal herbs and plants as 
complementary aids to routine 
pharamaceutical market products. 
 
The prophylactic and therapeutic effects of 
plant foods and extracts in reducing 
cardiovascular disease has been reviewed 
(Walker, 1996).  Non-nutrient 
phytochemicals are increasingly being 
recognized as potential health promoters I 
reducing the risks of cardiovascular disearse 
and atherosclerosis.  Prominent herbs 
identified were Achillea millefolium 
(yarrow), Allium Sativum (garlic), 
Convallaria majalis (lily of the Valley), 
(hawthorn), Cynara scolymus (globe 
artichoke), Gingko biloba (gingko) and 
Viburnum opulus (cramp bark). 
 
Saint-john’s work known as Johanniskrant 
in German for centuries has been used to 
treat people with mild and moderate 
depreassion without the side effects of 
Prozac.  Widely sold in Germany and other 
European countries, and awaiting official 
approval by the US food and Drug 
Administration, Saint-john’s wort is being 
regarded as a serious rival to Prozac 
(Andrews, 1997). 
 
Medicinal plants can make an important 
contribution to the WHO goal to ensure, by 
the year 2000, that all peoples, worldwide, 
will lead a sustainable social-economic 
productive life., The centre for Science and 
Technology of the Non-Aligned and other 
Developing Countries in India organized an 
international Workshop on Tissue Culture of 
Economic Plants in April, 1994, as a means 
of using modern biotechnological techniques 
to nurture and conserve medicinal plants. 
 
In late 1997, the World Bank, within the 
framework of the Global Environmental 
Facility provided a US $ 4.5 million grant 
for the SriLanka conservation of Medicinal 
Plants Project which focuses on the 
conservation of medicinal plant populations, 
their habitats, and their sustainable use in 
medicinal Plant conservation Areas 
(MPCAs), Inventories with emphasis on the 
management, research and conservation of 
rare and endangered species of medicinal 
plants are the main programmes at MPCAs 
at Ritigala, Naula, Rajawaka, Kanneliya and 
Bible. 
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Aspects of policy and research concerning 
the cultivation of non-tropical ad tropical 
medicinal plants and their genetic 
improvement; their conservation in botanical 
gardens, their storage in liquid nitrogen; 
their economic potential in international 
pharmaceutical trade; and their vulnerability 
to over- exploitation and extinction have 
been dealt with authoritatively (Akerele et 
al, 1991; Chadwick and Marsh, 1994). 
Moreover, such concerns and issues are 
addressed trough a variety of programme 
activities and projects conducted, and 
promoted by several international, regional, 
and non-governmental organizations 
(Table3) 
 
CONCLUDING REMARKS  
 
Recent and renewed interest in medicinal 
plants coupled to developments in 
information technology had fuelled an 
explosion in the range and content of 
electronic information concerning medicinal 
plants as a re-emergent health aid.  Bhat 
(1997) recently reviewed diverse sources of 
such information in traditional adstracting 
services as well as in a variety of online 
electronic databases.  As a result of such 
developments, access to indigenous people 
and cultures concerning medicinal plants are 
greatly facilitated.  Furthermore, the active 
participation of such natural custodians and 
practitioners of valuable knowledge is 
guaranteed in the generation of research 
focusing on screening programmes dealing 
with the isolation of bioactive principles and 
the development of new drugs. 
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